H.R. 3243: Therapeutic Fraud Prevention Act of 2025
The Therapeutic Fraud Prevention Act of 2025 aims to prohibit practices known as conversion therapy, which attempt to change an individual's sexual orientation or gender identity. The bill asserts that being lesbian, gay, bisexual, transgender, or gender nonconforming is not a disorder and highlights the lack of scientific evidence supporting conversion therapy. It emphasizes the significant risks associated with these practices, including mental health issues and increased rates of depression and suicide.
Key Definitions
- Conversion Therapy: Any treatment aimed at changing a person’s sexual orientation or gender identity, provided for monetary compensation.
- Gender Identity: A person's internal sense of their gender, which may differ from the sex assigned to them at birth.
- Sexual Orientation: Describes a person's emotional or sexual attraction to individuals of the same or different genders.
Provisions of the Act
The Act makes it unlawful for any individual or entity to:
- Provide conversion therapy.
- Advertise conversion therapy, suggesting it can change a person’s sexual orientation or gender identity, reduce same-gender attraction, or claim it is harmless.
- Assist or facilitate the provision of conversion therapy if receiving compensation.
Enforcement Mechanisms
The bill empowers the Federal Trade Commission (FTC) and state attorneys general to enforce these provisions:
- The FTC can treat violations as unfair or deceptive acts, with enforcement powers to impose penalties.
- The Attorney General can bring civil actions against violators.
- State attorneys general may act on behalf of residents adversely affected by violations.
Severability Clause
The bill includes a severability clause, ensuring that if any part of the Act is found unconstitutional, the rest remains effective.
Relevant Companies
None found.This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
101 bill sponsors
-
Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
-
Co-Sponsor
Actions
2 actions
Date | Action |
---|---|
May. 07, 2025 | Introduced in House |
May. 07, 2025 | Referred to the House Committee on Energy and Commerce. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.